Home Tags CD33-Targeted Antibody-Drug Conjugate

Tag: CD33-Targeted Antibody-Drug Conjugate

IMGN632, a Novel CD123-Targeting Antibody-drug Conjugate, Demonstrates Activity in Acute Myeloid...

Preclinical data on IMGN632, a novel CD123-targeting antibody-drug conjugate being developed by ImmunoGen, presented at the 58th American Society of Hematology (ASH) Annual Meeting...

IMGN779 Induces DNA Damage, Cell Cycle Arrest, and Apoptosis in AML...

CD33 is broadly expressed on leukemic blasts of patients with acute myeloid leukemia.  Although nearly 80% of patients show a high initial response rates to chemotherapy, many...